The FDA has accepted the biologics licensing application (BLA) resubmission for odronextamab, a potential treatment for ...
Merck (NYSE:MRK) shares were on track to snap six straight sessions of gains on Wednesday, as the stock fell 2.8% at $88.87 ...
A Tell City woman is facing charges of bigamy in Vanderburgh County for allegedly marrying her biological father. According ...
HENDERSON, Ky (WEHT) – A Tell City woman is facing charges of bigamy in Vanderburgh County for allegedly marrying her biological father. According to an affidavit, Evansville Police were notified ...
PRGN-2012—which Precigen has begun to call by its generic name of zopapogene imadenovec—is a gene therapy designed to elicit immune responses directed against cells infected with human papillomavirus ...
The US Food and Drug Administration (FDA) has accepted for review Regeneron Pharmaceuticals’ resubmission of the Biologics ...
The FDA accepted odronextamab’s biologics license application resubmission for relapsed/refractory follicular lymphoma after ...
If approved, PRGN-2012 would be the first treatment allowed by the FDA for the rare and chronic disease caused by HPV 6 and HPV 11.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission ...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License ...
The FDA accepted a supplemental biologics license application for Opdivo plus Yervoy as a first-line treatment for some adult ...